Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Nigerian (NSE) Healthcare Sector Analysis

UpdatedJun 05, 2026
DataAggregated Company Financials
Companies5
  • 7D0.2%
  • 3M46.1%
  • 1Y417.3%
  • YTD84.4%

In the last week, Healthcare has been flat. As for the the longer term, the industry is up 434% over the past 12 months. Earnings are forecast to grow by 24% annually.

Sector Valuation and Performance

Has the Nigerian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 05 Jun 2026₦836.5b₦256.3b₦24.0b37.6x34.9x3.3x
Sun, 03 May 2026₦591.9b₦250.0b₦23.1b28.7x25.7x2.4x
Tue, 31 Mar 2026₦593.6b₦242.4b₦21.2b31.9x28x2.4x
Thu, 26 Feb 2026₦679.2b₦240.5b₦20.0b37.1x34x2.8x
Sat, 24 Jan 2026₦714.7b₦236.4b₦17.8b24.4x40.2x3x
Mon, 22 Dec 2025₦378.6b₦160.6b₦12.5b9.8x30.2x2.4x
Wed, 19 Nov 2025₦259.7b₦160.6b₦12.5b9.4x20.7x1.6x
Fri, 17 Oct 2025₦270.2b₦149.5b₦11.8b11.3x23x1.8x
Sun, 14 Sep 2025₦242.7b₦149.5b₦11.8b10.8x20.6x1.6x
Tue, 12 Aug 2025₦226.0b₦148.8b₦11.8b11.8x19.2x1.5x
Thu, 10 Jul 2025₦230.0b₦137.4b₦9.3b13.4x24.8x1.7x
Sat, 07 Jun 2025₦158.4b₦137.4b₦9.3b10.2x17.1x1.2x
Mon, 05 May 2025₦114.6b₦132.3b₦10.1b6.8x11.3x0.9x
Wed, 02 Apr 2025₦103.3b₦113.1b₦6.7b8.2x15.3x0.9x
Fri, 28 Feb 2025₦108.3b₦113.1b₦6.7b8.2x16.1x1x
Sun, 26 Jan 2025₦124.9b₦103.4b₦3.8b8.8x33.3x1.2x
Tue, 24 Dec 2024₦105.3b₦103.4b₦3.8b8x28.1x1x
Thu, 21 Nov 2024₦104.7b₦103.4b₦3.8b7.8x27.9x1x
Sat, 19 Oct 2024₦107.3b₦92.5b₦2.0b10.9x53.8x1.2x
Mon, 16 Sep 2024₦91.2b₦92.5b₦2.0b9.6x45.7x1x
Wed, 14 Aug 2024₦93.7b₦92.5b₦2.0b10.2x47x1x
Fri, 12 Jul 2024₦93.5b₦84.8b₦2.1b8.4x43.7x1.1x
Sun, 09 Jun 2024₦90.9b₦84.8b₦2.1b8.5x42.5x1.1x
Tue, 07 May 2024₦96.2b₦84.6b₦1.9b9.1x51.4x1.1x
Thu, 04 Apr 2024₦96.5b₦75.0b₦1.7b10.9x57.3x1.3x
Sat, 02 Mar 2024₦95.3b₦75.0b₦1.7b10.5x56.6x1.3x
Mon, 29 Jan 2024₦129.4b₦85.6b₦4.7b16.8x27.4x1.5x
Wed, 27 Dec 2023₦126.4b₦85.6b₦4.7b11.3x26.7x1.5x
Fri, 24 Nov 2023₦103.8b₦85.6b₦4.7b11.2x22x1.2x
Sun, 22 Oct 2023₦66.9b₦82.7b₦5.7b7.8x11.6x0.8x
Tue, 19 Sep 2023₦68.6b₦82.7b₦5.7b8.2x11.9x0.8x
Thu, 17 Aug 2023₦66.1b₦83.1b₦6.1b8.1x10.9x0.8x
Sat, 15 Jul 2023₦67.9b₦81.7b₦6.1b8.1x11.1x0.8x
Mon, 12 Jun 2023₦50.6b₦81.7b₦6.1b5.3x8.3x0.6x
Price to Earnings Ratio

8.3x


Total Market Cap: ₦50.6bTotal Earnings: ₦6.1bTotal Revenue: ₦81.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Nigerian Healthcare Sector Price to Earnings3Y Average 28.9x202420252026
Current Industry PE
  • Investors are optimistic on the Nigerian Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 35.0x which is higher than its 3-year average PE of 28.9x.
  • The 3-year average PS ratio of 1.4x is lower than the industry's current PS ratio of 3.3x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 58% per year over the last three years.
  • Revenues for these companies have grown 46% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Nigerian Healthcare sector?

NG Market-3.42%
Healthcare0.19%
Pharma0.19%
Healthcare Services0%0
Industry PE
  • Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 28.3x.
    • Analysts are expecting annual earnings growth of 24.5%, which is lower than the prior year's growth of 116.3% per year.
  • Investors are most pessimistic about the Pharma industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 28.3x.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 24% over the next 5 years.
  • However this is lower than its past earnings growth rate of 116% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 24% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NEIMETH Neimeth International Pharmaceuticals₦10.602.4%
+₦1.1b		217.4%PE46x
MAYBAKER May & Baker Nigeria₦47.000.6%
+₦517.6m		240.6%PE17.8x

Latest News

NEIMETH
₦10.60
Neimeth International Pharmaceuticals
7D
2.4%
1Y
217.4%
Narrative Update • May 21

Neimeth International Pharmaceuticals Plc – ₦2.44bn Rights Issue

Recapitalisation to Strengthen Operations & Expand Production Capacity Transaction Overview Analyst: Qudus Adebara (Research Analyst, DLM Securities) Neimeth International Pharmaceuticals Plc has commenced trading of its ₦2.44 billion rights issue on the Nigerian Exchange Limited (NGX) , as part of its capital raising and business expansion strategy. Offer Size: 610,443,515 ordinary shares Par Value: 50 kobo per share Offer Price: ₦4.00 per share Rights Ratio: 1 new share for every 7 existing shares Offer Opens: April 27, 2026 Offer Closes: May 25, 2026 Total Capital Raise: ~₦2.44 billion Shareholders can trade their rights on the NGX via a dedicated rights trading code.
MAYBAKER
₦47.00
May & Baker Nigeria
7D
0.6%
1Y
240.6%